Janux Therapeutics, Inc. ($JANX)
Filing Information
| Accession Number | 0001231919-26-000631 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 13, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
21,000
Total Value
$0.00
P&L
+inf% (+$318,570.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jun 11, 2026 | Grant/Award | 5,500 | $0.00 | $0.00 | 11,750 | Indirect | See footnotes | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jun 11, 2026 | Grant/Award | 15,500 | $0.00 | $0.00 | 15,500 | Indirect | See Footnotes | View Details |